Nav: Home

Global malaria spending $2 billion short of WHO target, stifling progress

April 25, 2019

  • New study reveals wide variation in spending across the 106 countries, based on whether countries are seeking to control the disease or eliminate it

  • Development assistance for malaria has plateaued, with 2018 levels virtually unchanged since 2010

  • Flat-lined funding threatens to stall progress in some low-income countries

SEATTLE - A first-of-its-kind study reveals malaria spending in 2016 totaled $4.3 billion globally, far short of the annual funding target of $6.6 billion set by the World Health Organization.

"A persistent challenge remains as funds are stagnating," said Dr. Joseph Dieleman, a senior author on the study, health economist, and assistant professor at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine. "More resources are needed. This is particularly evident in the poorest countries, especially as they seek to control, or even eliminate, the disease."

An increase of more than 50% in resources is needed annually to bridge the considerable $2.3 billion gap and meet the WHO target.

Dieleman emphasized that the first-of-its-kind study fills a major gap in understanding spending on malaria globally. Published today in the international medical journal The Lancet Infectious Diseases, the analysis provides comprehensive and comparable estimates of total spending on the disease, and also tracks government, out-of-pocket, and donor spending.

"These estimates empower donors, including government agencies, corporations, foundations, and philanthropists, as well as each country's national malaria control program, to evaluate how best to fill crucial gaps between current financing and fast-approaching global targets," he said.

The study spans from 2000 to 2016 and covers 106 countries organized into three groups: malaria control countries, malaria elimination countries, and countries that eliminated the disease after 2000. Malaria control countries are those seeking to aggressively control the disease in high-burden areas, whereas malaria elimination countries have formally declared, or are strongly considering, an evidence-based goal to halt malaria transmission nationally.

Researchers found malaria funding sources shifted substantially over the 17-year study period. Government expenditures accounted for more than half (55.3%, or $643 million) of global malaria spending in 2000, but constituted a much smaller share in 2016 at 28.2% ($1.2 billion). By comparison, government spending accounted for 60.1% of global spending for HIV/AIDS the same year in the 106 countries in the study.

Conversely, development assistance for malaria was a major driver of overall growth in malaria spending between 2000 and 2016, increasing 18.0% per year. At $2.4 billion in 2016, development assistance represented more than half (56.5%) of total malaria spending that year, up from 14.7% ($171 million) in 2000.

While development assistance for malaria accounted for more than $10 billion in total spending between 2000 and 2010, it plateaued in recent years, with 2018 levels virtually unchanged since 2010. To sustain progress, study authors noted funding above current levels of development assistance for malaria is needed.

"We are 11 years away from the date set by the United Nations for 'ending the epidemic' of malaria," lead author Annie Haakenstad said. "The world is watching, and unless more financial resources emerge, that goal will represent a great lost opportunity."

Additionally, the study exposes wide variations in malaria spending across the 106 countries, depending on whether countries were seeking to control the spread of the disease or eliminate it. Between 2000 and 2016, nearly $30 billion was spent on malaria in the 47 control countries, representing the bulk (72.8%) of total spending globally on the disease. $2.6 billion was spent in these countries in 2016 alone.

Findings demonstrate that as malaria incidence declines toward zero, government financing becomes by far the largest source of financing. In 2016, governments in elimination countries contributed a larger share (47.9%) of malaria spending than those in control countries (28.3%).

Additional findings include:
  • The United States government has been the largest source of malaria funding since 2008, with a contribution of $876 million in 2018 alone.
  • In terms of disbursements, the largest shares of development assistance for malaria in 2018 were distributed through the Global Fund ($1.0 billion, or 42.6% of the total) and US bilateral aid agencies including the President's Malaria Initiative ($374 million, or 15.5% of the total).
  • The share of malaria spending sourced out-of-pocket declined from 26.4% ($307 million) in 2000 to 13.0% ($556 million) in 2016, and is highest in countries with the largest malaria burden.
  • Between 2000 and 2016, a quarter ($10.1 billion) of total malaria spending occurred in the 41 eliminating countries, with $854 million expended in 2016 alone.
  • In 2016, malaria spending in control countries was $14 per incident case on average; this amount was twice as high, $28, in elimination countries, due in part to lower incidence.
  • With four of every five malaria cases globally occurring in sub-Saharan Africa, the share of malaria spending in the region in 2016 amounted to $2.7 billion, or 62.8% of global malaria spending.
Highest total spending on malaria ($USD), 2016
  1. Nigeria: $424.4 million
  2. Democratic Republic of the Congo: $189.2 million
  3. Tanzania: $183.6 million
  4. Uganda: $173.9 million
  5. Ghana: $172.0 million
  6. Mozambique: $131.4 million
  7. Angola: $119.9 million
  8. Zambia: $119.5 million
  9. India: $118.6 million

Countries with largest fraction of malaria spending that is out-of-pocket (%), 2016
  1. Niger: 58.4%
  2. Cameroon: 51.6%
  3. Somalia: 47.6%
  4. Nigeria: 37.8%
  5. Equatorial Guinea: 35.0%
  6. Sierra Leone: $32.6%
  7. India: 28.4%
  8. Republic of the Congo: 27.5%
  9. Yemen: 27.5%
  10. Ghana: 24.8%

Countries with largest fraction of malaria spending that is development assistance (%), 2016
  1. Madagascar: 91.8%
  2. Haiti: 86.8%
  3. Afghanistan: 85.1%
  4. Comoros: 85.1%
  5. Laos: 84.9%
  6. Guinea-Bissau: 83.6%
  7. Senegal: 82.5%
  8. Rwanda: 82.4%
  9. The Gambia: 81.4%
  10. Chad: 81.3%

The study is entitled "Tracking spending on malaria by source in 106 countries, 2000-2016: an economic modelling study."
Media contacts:

IHME: Kelly Bienhoff, +1-206-897-2884 (office); +1-913-302-3817 (mobile);
IHME: Dean Owen, +1-206-897-2858 (office); +1-206-434-5630 (mobile);
The Lancet: Emily Head +44-207-424-4249 (office); +44-7920-530-997 (mobile);

About the Institute for Health Metrics and Evaluation

The Institute for Health Metrics and Evaluation (IHME) is an independent global health research organization at the University of Washington that provides rigorous and comparable measurement of the world's most important health problems and evaluates the strategies used to address them. IHME is committed to transparency and makes this information widely available so that policymakers have the evidence they need to make informed decisions on allocating resources to improve population health.

Institute for Health Metrics and Evaluation

Related Malaria Articles:

Could there be a 'social vaccine' for malaria?
Malaria is a global killer and a world health concern.
Transgenic plants against malaria
Scientists have discovered a gene that allows to double the production of artemisinin in the Artemisia annua plant.
Fighting malaria through metabolism
EPFL scientists have fully modeled the metabolism of the deadliest malaria parasite.
Should we commit to eradicate malaria worldwide?
Should we commit to eradicate malaria worldwide, asks a debate article published by The BMJ today?
Investigational malaria vaccine shows considerable protection in adults in malaria season
An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria -- the deadliest form of the disease -- for the duration of the malaria season, according to new findings published in the Feb.
Why malaria mosquitoes like people with malaria
Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria.
Malaria superbugs threaten global malaria control
A lineage of multidrug resistant P. falciparum malaria superbugs has widely spread and is now established in parts of Thailand, Laos and Cambodia, causing high treatment failure rates for the main falciparum malaria medicines, artemisinin combination therapies (ACTs), according to a study published today in The Lancet Infectious Diseases.
Considering cattle could help eliminate malaria in India
The goal of eliminating malaria in countries like India could be more achievable if mosquito-control efforts take into account the relationship between mosquitoes and cattle, according to an international team of researchers.
Seasonal malaria chemoprevention in Senegalese children lowers overall malaria burden
Giving preventive antimalarial drugs to children up to age 10 during active malaria season reduced the cases of malaria in that age group and lowered the malaria incidence in adults, according to a randomized trial carried out in Senegal and published in PLOS Medicine by researchers from the Université Cheikh Anta Diop, Senegal, the London School of Hygiene & Tropical Medicine, UK, and other collaborators.
How malaria fools our immune system
OIST researchers reconstruct the 3-D structure of a malaria protein in combination with human antibodies.

Related Malaria Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...